Middle East Pharmaceutical Industries Company
4016
Rank in Stocks
#11229
Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh,... Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh, Saudi Arabia, in 1998, is a global pharmaceutical entity. The company's core activities encompass the entire lifecycle of generic medicines and various pharmaceutical products, from research and development to manufacturing and sales, catering to both local and international markets. Its business operations are strategically divided into private sector, public sector, and export divisions. MEPIC offers an extensive array of products designed to address a wide range of medical conditions. This includes dermatological treatments, remedies for respiratory ailments, central nervous system disorders, digestive issues, and musculoskeletal complaints, alongside medications for the urinary and reproductive systems. Furthermore, the company provides disinfectants and a diverse portfolio of therapeutic agents covering areas such as sexual health, diabetes, cardiovascular diseases, anti-infectives, anti-parasitics, pain relief, antiseptics, and general men's and women's health. These pharmaceutical and health products are supplied in numerous formats, including creams, ointments, syrups, capsules, tablets, gels, lotions, sprays, topical solutions, and personal hygiene items like hand sanitizers, mouthwashes, and soaps. In addition to its proprietary product lines, MEPIC leverages its manufacturing capabilities to offer contract manufacturing services. The company also specializes in cosmetic products, general health aids, and nutritional supplements. Originally known as Middle East Chemical Products Factory Company, the organization officially rebranded to Middle East Pharmaceutical Industries Company in January 2006.
Share Price
$16.86
Last synced: 2026-11-11
Market Cap
$591.24M
Change (1 day)
0.08%
Change (1 year)
-10.27%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Middle East Pharmaceutical Industries Company (4016)
Category
Healthcare
Operating Margin for Middle East Pharmaceutical Industries Company (4016)
Operating Margin as of November 2026 TTM: 23.88%
According to Middle East Pharmaceutical Industries Company's latest financial reports, its current operating margin (TTM) is 23.88%. At the end of 2025 the company had an operating margin of 23.54%.
Operating Margin history for Middle East Pharmaceutical Industries Company from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 23.88% | 1.44% |
| 2025 | 23.54% | 1.86% |
| 2024 | 23.11% | -0.04% |
| 2023 | 23.12% | -0.52% |
| 2022 | 23.24% | -12.76% |
| 2021 | 26.64% | -0.86% |
| 2020 | 26.87% | 3.35% |
| 2019 | 26.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -97.39% |
US
|
|
| 31.60% | -98.68% |
SE
|
|
| 30.13% | -98.74% |
FR
|
|
| 29.76% | -98.75% |
HK
|
|
| 30.46% | -98.72% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Middle East Pharmaceutical Industries Company's operating margin
What is Middle East Pharmaceutical Industries Company's operating margin?
Middle East Pharmaceutical Industries Company's operating margin is 23.88%, as of Nov 2026.
What was Middle East Pharmaceutical Industries Company's operating margin in 2025?
In 2025, Middle East Pharmaceutical Industries Company's operating margin was 23.54%, compared with 23.11% in 2024.
How has Middle East Pharmaceutical Industries Company's operating margin changed since 2020?
From 2020 to 2025, Middle East Pharmaceutical Industries Company's operating margin was highest in 2020 (26.87%) and lowest in 2024 (23.11%).
How does Middle East Pharmaceutical Industries Company's operating margin compare with similar companies?
Middle East Pharmaceutical Industries Company's operating margin (23.88%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.